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background: Ultrasound-guided transvaginal oocyte retrieval is often performed under local anaesthesia on an outpatient basis. The
objective of this study was to compare the overall pain experience of a newly designed reduced needle (RN) compared with a thicker stan-
dard needle (SN).
methods: A prospective, randomized, multi-centre study was performed at four different clinics from June to December 2009. The
oocyte aspiration was performed under local anaesthesia, either with a needle with a reduced diameter (0.9 mm) for the last 50 mm
from the tip (RN) or with a SN (1.4 mm). A total of 257 patients were randomized (RN: n ¼ 129; SN: n ¼ 128). The primary endpoint
was the overall pain experience self-assessed and registered by the patient on a visual analogue scale (VAS 0 mm ¼ no pain to
100 mm ¼ unbearable pain) immediately after the oocyte retrieval. Secondary end-points such as vaginal bleeding and several embryological
parameters were also registered.
results: The overall pain during the oocyte retrieval procedure was signiﬁcantly lower in the RN group than in the SN group (mean
21.0 mm, SD 17.5 mm and median 19.0 mm versus mean 26.0 mm, SD 19.9 mm and median 24.0 mm; P ¼ 0.040, difference between
groups mean25.0 mm, 95% CI: 9.7 to20.4). This was also true when adjusting for baseline characteristics such as number of follicles,
number of previous oocyte pick-up, body mass index and age, by a multiple linear regression analysis. Signiﬁcantly more patients (40 of
126) had less than expected vaginal bleeding in the RN group when compared with the SN group (24 of 124; 32 versus 19%; P ¼ 0.03
and 95% CI 1.7–23.0%). No differences were found between the two needles with regard to additional i.v. analgesia, aspiration time,
oocyte recovery, fertilization, cleavage rate, number of good quality embryos, number of embryos for freezing and pregnancy rate.
conclusions: Oocyte aspiration performed with the newly designed thinner-tipped needle resulted in signiﬁcantly less overall pain and
less vaginal bleeding, without prolonging the retrieval procedure or inﬂuence the oocyte recovery rate, when compared with a SN.
Clinicaltrials.gov: NCT00924885
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Introduction
Ultrasound-guided transvaginal follicle aspiration has become the gold
standard for oocyte pick-up (OPU) in human in vitro fertilization (IVF)
over the last 20 years. The technique has proved to be both efﬁcient
and safe. (Ludwig et al., 2006; Wikland, 2007). One of the advantages
of the technique is that it can be performed under local anaesthesia.
Since oocyte retrieval under local anaesthesia can be painful, different
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most commonly used method is conscious sedation with or without
a paracervical block (PCB; Ditkoff et al., 1997; Bokhari and Pollard,
1999). This means that the patient has some kind of light intravenous
sedation. Studies have suggested superior pain relief with conscious
sedation in combination with a PCB compared with sedation alone
(Corson et al., 1994; Ng et al., 1999). However, owing to the fact
that patients may experience pain during the procedure, many IVF
groups still use general anaesthesia despite OPU then becoming
more complicated and expensive since full anaesthesiological service
for each procedure is required. Although the best type of analgesia
for oocyte retrieval has not yet been established, local anaesthesia
in combination with conscious sedation is probably the most fre-
quently used. However, very little attention has been paid to the tech-
nical aspects, such as needle design and the effect on pain experience.
There are only two published studies where pain experience in relation
to the needle diameter has been explored (Aziz et al., 1993; Awonuga
et al., 1996). In these studies, signiﬁcantly less pain was experienced
when the needle was reduced from 15 and 16 gauge to 17 and 18
gauge. It remains unknown whether an even thinner needle might
cause less pain when the OPU procedure is performed under local
anaesthesia. Reducing the needle diameter too much (,0.8 mm),
however, may be a problem with regard to damage to the oocyte
(Cohen et al., 1986). Another problem with a very thin needle is that
it may miss the target, thereby making the retrieval technically more dif-
ﬁcult and less efﬁcient. In order to circumvent these problems, a new
needle has been designed where only the last 50 mm of the needle is
reduced in diameter. Thus, only the part of the needle that penetrates
into the tissues is reduced in diameter. In order to determine whether
this new needle results in less pain compared with a standard needle
(SN), a prospective randomized study was designed.
The aim of this study was to compare the pain experience during
oocyte retrieval between a newly designed thinner needle and a
thicker SN.
Materials and Methods
A prospective, randomized, comparative, multi-centre study was per-
formed at the Fertility Centre Carlanderska Hospital, Gothenburg,
Sweden; Centre for Reproductive Medicine, University Hospital, Malmo ¨,
Sweden; Fertility Unit at Karolinska University Hospital, Huddinge, Stock-
holm, Sweden and the IVF Clinic Falun, Falu Hospital, Falun, Sweden
between June and December 2009.
The Ethics Committee at the University of Go ¨teborg approved the
study. All patients who were included gave their written informed
consent. The study was registered at the ClinicalTrial.Gov, study
number NCT00924885.
The patient population consisted of all patients who were going to have
oocyte aspiration performed at the four clinics during the study period.
Patients were eligible for randomization if they fulﬁlled the following cri-
teria: (i) signed the written consent, (ii) had the oocyte aspiration under
local anaesthesia and (iii) were Swedish-speaking. The exclusion criteria
were as follows: (i) previous participation in the study, (ii) body mass
index (BMI) ≥35 and (iii) other contraindications for oocyte aspiration.
Randomization
Patients were randomized by a nurse on the day of oocyte retrieval, using
electronic locally installed randomization programme, to either the
reduced needle (RN) group or the SN group. Randomization was 1:1
with optimal allocation according to Pocock’s minimization technique for
sequential randomization (Pocock, 1983). Consideration was given to
the woman’s age, number of previous oocyte aspirations, pre-medication
and the number of follicles with an external diameter exceeding 10 mm at
the last ultrasound before oocyte aspiration. The patient was blinded to
which group she had been randomized into. For practical reasons, the
doctor and the nurse were not blinded to patient randomization group.
The study ﬂow chart of patients randomized is shown in Fig. 1.
Rating of pain
Rating of pain was performed by self-assessment by means of visual ana-
logue scale (VAS) consisting of a line oriented vertically on a paper with
a range from 0 mm (no pain) to 100 mm (unbearable pain) (McCormack
et al., 1988). Immediately after the oocyte aspiration and before the
patient had been given the ﬁnal result of the number of oocytes retrieved,
she was asked by a nurse to rate the ‘overall pain for the whole pro-
cedure’. This was the primary end-point. The nurse only asked the
patient to put a mark on the vertical line on the paper with the VAS.
All data were recorded on a case report form, which was transferred
manually into an electronic database for analysis. The database was
quality-controlled by two individuals who double checked all parameters.
They independently measured the marks on the VAS. All data input was
done blinded from group allocation.
Ovarian stimulation and oocyte aspiration
Ovarian stimulation was performed using follicle-stimulating hormone or
human menopausal gonadotrophin in combination with GnRH agonists
or antagonists according to each clinic’s routines. Dosage was set individu-
ally, taking into account age, menstrual cycle length, smoking habits, BMI,
the number of pre-antral follicles and, whenever appropriate, the previous
response. Ovarian response was monitored by transvaginal ultrasound and
serum estradiol when necessary. Oocyte retrieval was carried out 36–
38 h after hCG injection (Bergh et al., 1997). Standard IVF or ICSI was
used according to the indication for the treatment.
Transvaginal oocyte retrieval was performed under local anaesthesia
(see below) and under guidance of ultrasound with either the RN with
an outer diameter of 0.9 mm (20 gauge) and inner diameter of 0.6 mm
for the last 50 mm from the tip of the needle and an outer diameter of
1.4 mm (17 gauge) and inner diameter of 1 mm for the remaining length
of the needle (Fig. 2) or the SN with an outer diameter of 1.4 mm (17
gauge) and inner diameter of 1 mm for the whole length of the needle
(Fig. 2). Both needles were provided by the manufacturer (Vitrolife
Sweden AB, Go ¨teborg, Sweden). The puncture procedure was performed
according to each clinic’s standard routine. Aspiration pressure was kept at
a negative pressure between 90 and 120 mmHg. All the physicians
(n ¼ 13) performing the oocyte retrievals were skilled, had many years
of experience and used the same technique.
Laboratory procedures such as culturing and freezing techniques were
performed according to each laboratory’s standard technique. Embryo
transfer was performed on Day 2, 3 or 5 according to each clinic’s routine.
Sedation and local anaesthesia
Pre-operatively, all patients received paracetamol 1 g (Panodil 1 g; Glaco
Smith Kline, Ta ¨by, Sweden). All patients had a PCB with 10 ml of 1%
(10 mg/ml) lidocaine (AstraZeneca, So ¨derta ¨lje, Sweden) and were given
a total dose of 100 mg, using a needle of 0.9 mm diameter and 120 mm
length (Mediplast AB, Malmo ¨, Sweden). Additionally, all patients received
alfentanil (Rapifen 0.5 mg/ml; Janssen-Cilag AB, Sollentuna, Sweden)
0.25 mg i.v. immediately before the PCB was given. If needed (patient
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Figure 1 Flow chart of patients for the study.
Pain experience at OPU between two different needles 1379request), a supplementary dose of 0.25 mg alfentanil was given up to three
times, and the total dose was recorded.
Secondary end-points
Vaginal bleeding during or after the procedure was graded subjectively by
the physician as (i) less than normal, (ii) normal or (iii) more than normal.
This was considered the second most important parameter.
Aspiration time was measured from the time the ﬁrst follicle was punc-
tured until the last follicle had been aspirated and the needle withdrawn.
The number of follicles aspirated as well as the number of oocytes, the
number of fertilized oocytes, the number of embryos cleaved (of normally
fertilized), the number of good quality embryos (¼transferred + frozen
embryos), the number of embryos transferred and the number of
embryos frozen were registered. Clinical pregnancy was deﬁned as gesta-
tional sac seen on ultrasound at least 5 weeks after transfer.
Furthermore, secondary end-points were also the patients rating of (i)
the maximum pain, (ii) pain they experienced directly after the oocyte
aspiration, (iii) 30 min and (iv) 60 min after the procedure.
Sample size calculation and statistical
analysis
The primary end-point was the ‘overall pain experience’, evaluated as
described previously. Assuming the mean overall pain in the RN group
to be 27 mm (value chosen after analysis of data from a previous study
from our group, Cerne et al., 2006) on VAS, with a standard deviation
(SD) of 21.5 mm (based on analysis of data from a previous study
Cerne et al., 2006), 121 patients in each group would be needed to
demonstrate a decrease in overall pain of 8 mm (30%) with 80% power
and a signiﬁcance level of 0.05 (two-tailed tests).
Continuous variables were described with mean, SD, median and range
and categorical variables as n and percent. For comparison between the
two groups, Fisher’s exact test was used for dichotomous variables,
Mantel–Haenszel x
2 test for ordered categorical variables and Mann–
Whitney U-test for continuous variables. Calculation of conﬁdence interval
of differences in means between the two groups for continuous variables
was based on the assumption of normality.
All signiﬁcance tests were two-tailed and conducted at the 0.05 signiﬁ-
cance level. All statistical analyses were performed using SAS 9.2 (SAS
Institute Inc., Cary, NC, USA).
Results
Two hundred and ﬁfty-seven (n ¼ 257) patients were randomized.
Due to practical reasons, 482 patients could not be invited to partici-
pate in the study even though they fulﬁlled the criteria to participate
(Fig. 1). Three clinics recruited 70 patients and one clinic 47 patients.
One hundred and twenty-nine were allocated to the RN group and
128 to the SN group. Furthermore, in the RN group, three patients
were excluded due to protocol violations, resulting in 126 assessed
per protocol (PP). In the SN group, one patient was excluded after
randomization at her own request, and three were excluded due to
protocol violations, resulting in 124 assessed PP (Fig. 1).
No patient was lost to follow-up.
There were no differences in patient characteristics between the
two groups irrespective of whether data were analysed per
intention-to-treat (ITT) or PP (Table I).
Pain rating of OPU
The overall pain (primary end-point) for the whole procedure was
rated signiﬁcantly less by means of VAS in the group where the RN
was used, irrespective of whether analysed by ITT (mean 21.4
versus 26.0 mm) or PP (mean 21.0 versus 26.0 mm), corresponding
to a 19% pain reduction (see Table II).
When adjusted for baseline characteristics, such as number of fol-
licles at last ultrasound scan before OPU, previously performed
OPU, BMI and age, by use of a multiple linear regression analysis,
there is still signiﬁcantly less overall pain in the RN group when com-
pared with the SN group (P ¼ 0.034).
Secondary end-points of pain variables, maximum pain, pain experi-
ence directly after 30 and 60 min after the procedure did not differ
between the groups (Table III).
Secondary end-points
A signiﬁcant difference was found between the two groups in the
assessment of bleeding (see Table IV). Signiﬁcantly more patients
had less vaginal bleeding than expected when the RN was used,
........................................................................................
Table I Patient characteristics, given as mean+ + + + +SD
(range) per protocol population
RN (n 5 126) SN (n 5 124)
Age 34.2+4.7 (24–44) 34.4+4.2 (24–43)
BMI 23.2+3.6 (17–35) 23.7+3.4 (19–35)
No. of follicles at the last
scan before OPU
10.7+5.6 (2–40) 10.3+4.6 (2–35)
Previously performed OPU 1.34+1.54 (0–6) 1.37+1.81 (0–12)
No imbalances were observed among the patient characteristics recorded.
OPU, oocyte pick-up.
........................................................................................
Table II Primary end-point, measurements of VAS,
mm; mean+ + + + +SD (range)
RN SN P-value 95% CI
Intention to
treat
n ¼ 129 n ¼ 127
Overall pain
during OPU
21.4+18.1
(0–78)
n ¼ 128
a
26.0+19.7
(0–84)
n ¼ 126
b
0.047 29.24 to
0.11
Per population n ¼ 126 n ¼ 124
Overall pain
during OPU
21.0+17.5
(0–78)
n ¼ 125
a
26.0+19.9
(0–84)
n ¼ 123
b
0.040 29.72 to
20.36
Mann–Whitney U-test was used to compare differences in means between the two
groups. Calculation of conﬁdence interval of differences in means between the two
groups was based on the assumption of normality.
OPU, oocyte pick-up.
aOne patient could not register VAS immediately after OPU owing to severe drop in
blood pressure.
bOne patient did not want to register VAS owing to disappointment about the few
oocytes retrieved.
1380 Wikland et al.32% (40 of 126) versus 19% (24 of 124); P ¼ 0.029, 95% CI (1.7–
23.0%).
If also adjusting for the above-mentioned baseline characteristics
and vaginal bleeding by use of a multiple logistic regression, there is
still signiﬁcantly more patients with less vaginal bleeding than expected
in the RN group when compared with the SN group [P ¼ 0.022, 95%
CI (0.28–0.90)].
There were no difference in aspiration time, oocytes recovered,
damage to oocytes, fertilization rate, cleavage rate, proportion of
good quality embryos, implantation and clinical pregnancy rate
between the two groups, as presented in Table IV. Furthermore,
there was no difference between the groups with regard to the
number of patients who requested more i.v. analgesia (Table III).
No clinically important adverse events were observed in either of
the groups.
Discussion
The overall pain during oocyte aspiration was signiﬁcantly reduced in
the group with the thinner needle when compared with the SN.
The reduction in overall pain as measured by self-assessment on a
VAS scale was 19%. Furthermore, signiﬁcantly more patients had
less vaginal bleeding than expected. No negative effects were found
in relation to the oocyte or the outcome of the treatment.
Evaluating pain experience during oocyte retrieval is difﬁcult since
there are so many factors that inﬂuence pain, fear of pain, anxiety,
type of analgesia, physician’s skill and technical factors such as
needle diameter and sharpness. These factors have a clear inﬂuence
on pain threshold (Scott et al., 1983), and are therefore a potential
source of bias. In this study, one such factor that could be of impor-
tance is the fact that the doctor was not blinded to the type of needle.
.............................................................................................................................................................................................
Table IV Secondary end-points, treatment and outcome variables,+ + + + +mean (range) when applicable
RN (n 5 126) SN (n 5 124) P-value
Bleeding
No. of patients with less than expected bleeding (%) 40 (31.7) 24 (19.4) 0.042
No. of patients with normal bleeding (%) 80 (63.5) 93 (75.0)
No. of patients with more than normal bleeding (%) 6 (4.8) 7 (5.6)
Total OPU time (min) 7.72+4.10 (1–22) 7.52+3.73 (3–20) 0.85
Oocyte recovery/follicle (%) 77.2+24.2 73.4+25.4 0.27
No. of mature oocytes 7.57+5.31 (0–27) 7.34+4.91 (0–27) 0.91
No. of damage oocytes 0.41+1.23 (0–8) 0.43+1.20 (0–10) 0.67
Fertilization rate (%) 72.7+25.8 70.2+26.3 0.53
Cleavage rate
a (%) 70.8+26.6 68.5+25.6 0.50
No. of transferred embryos 1.06+0.54 (0–2) 1.07+0.55 (0–2) 0.89
No. of frozen embryos 1.30+2.04 (0–12) 1.28+1.89 (0–8) 0.80
Proportion of good quality of embryos (%)
b 27.9+20.2 29.8+23.5 0.64
Implantation rate (%) 21.6+42.4 25.9+44.6 0.40
Clinical pregnancy rate (%) 19.8 24.4 0.48
Analysis per protocol population.
OPU, oocyte pick-up.
aOf normally fertilized.
bFor deﬁnition of good quality of embryos see main text (Materials and Methods).
.............................................................................................................................................................................................
Table III Secondary end-point, measurements of VAS, mm; mean+ + + + +SD (range)
RN (n 5 126) SN (n 5 124) P-value 95% CI
Pain directly after OPU 13.9+17.3 (0–77) 13.3+15.0 (0–74) 0.53 23.50 to 4.64
Maximum pain after OPU 33.6+26.0 (0–96) 39.1+24.4 (0–96) 0.06 211.81 to 0.79
Pain 30 min after OPU 17.6+18.6 (0–72) 18.0+19.7 (0–98) 0.66 25.20 to 4.38
Pain 60 min after OPU 10.8+13.7 (0–61) 11.8+14.3 (0–69) 0.27 24.54 to 2.53
% patients who requested more i.v. analgesia 25.4 31.5 0.36 218.3 to 6.40
% patients with ,30 mm on VAS in overall pain during OPU 70.4 61.0 0.14 20.31 to 0.22
Analysis per protocol population. Mann–Whitney U-test was used to compare differences in means between the two groups. Calculation of conﬁdence interval of differences in means
between the two groups was based on the assumption of normality.
OPU, oocyte pick-up.
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needle in use, since the needles are easily distinguishable on the ultra-
sound screen. This is of course a weakness of the study. Another
factor that might introduce bias is the lack of blinding of the study
nurses. We consider that this is of minor relevance since the
nurse’s involvement was limited to asking the patient to mark the
VAS. The nurse’s knowledge of which needle was used is thus not
believed to inﬂuence the patient’s experience of pain. Furthermore,
there is no objective method for evaluating pain.
Despite those problems, several studies have tried to evaluate the
patient’s pain experience during oocyte retrieval, mainly focusing on
the method for analgesia.
A Cochrane review of such studies concluded that there is insufﬁ-
cient evidence to determine the best method of pain relief for OPU
(Kwan et al., 2005). It is interesting to note that technical factors
such as needle diameter and type of bevel have largely been neglected
with regard to pain related to oocyte retrieval. Almost from the start
of human IVF, it has been assumed that an ‘ideal’ follicle aspiration
needle should have an inner diameter of at least 0.8 mm, which
means that the outer diameter will be between 1.2 and 1.4 mm
(16–18 gauge) depending on the wall thickness of the needle
(Lopata et al., 1974). The background for choosing the diameter men-
tioned above is that such a diameter has, in several studies, proved to
result in good recovery rates and a low frequency of damage to
oocytes (Renou et al., 1981; Belaisch-Allart et al., 1985).
Our results with less overall pain experience in the group where the
RN was used is supported by a study by Awonuga et al., who found a
signiﬁcant reduction in how patients perceived pain when oocyte
retrieval needle size was decreased from 15 gauge to either 17 or
18 gauge. However, that study evaluated pain using a questionnaire
answered by patients post-operatively and not VAS (Awonuga et al.,
1996). In another interesting although small study where VAS was
used, it was clearly shown that the patient experienced less pain on
the side where a thinner needle (16 versus 18 gauge) was used
(Aziz et al., 1993).
The limit of 30 mm on a VAS is often used for administration of
analgesics post-operatively (Rawal and Berggren, 1994). However,
there was no statistically signiﬁcant difference between patients
below 30 mm on the VAS scale in the RN group when compared
with the SN group (Table III).
In conclusion, our results indicate that a needle as thin as 20 gauge
does result in a reduction of the overall pain as measured by VAS. Fur-
thermore, even though not objectively measured, we also found a sig-
niﬁcant difference in the number of patients with less than expected
vaginal bleeding between the two needles. The lower proportion of
patients with less than expected vaginal bleeding indicate that the
needle could be less traumatic.
It is reassuring that the thinner needle does not seem to have any
negative effects on the cumulus oocyte complex. The reason for
this might be that the thinner part of the needle is very short. The
low proportion of damaged oocytes in our study is very similar to
what has been reported in another prospective randomized controlled
study where two different needles were tested (Miller et al., 2004);
however, larger studies are needed to conﬁrm this ﬁnding.
Although, one might expect that a reduction of the inner diameter
of the needle by as much as 40% would inﬂuence the recovery rate
and/or the total aspiration time; however, this was not the case in
our study. The reason may be that only a very short part of the
needle was reduced.
Very few studies have investigated the importance of the needle
design for the oocyte recovery and possible damage to the cumulus
oocyte complex in clinical IVF. In studies on bovine oocytes, it has
been demonstrated that both the diameter and bevel of the needle,
as well as the aspiration vacuum, is important for the recovery rate
and developmental competence of the oocyte (Bols et al., 1996,
1997). In this study, human oocytes were unaffected by needles as
thin as 20 gauge and an aspiration pressure of 90–120 mmHg.
In conclusion, oocyte aspiration performed with the RN resulted in
signiﬁcantly less overall pain and less vaginal bleeding without prolong-
ing the retrieval procedure or inﬂuencing the oocyte recovery rate,
compared with a SN. Furthermore, no adverse effects on the
oocyte were found, as evaluated by the outcome of the IVF pro-
cedure. The thin tip needle, therefore, seems to be advantageous
for the patient.
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